Results 1 to 10 of about 402 (116)
Anti-Inflammatory Mechanisms of Novel Synthetic Ruthenium Compounds
Applied Sciences, 2021 Inflammation is the primary biological reaction to induce severe infection or injury in the immune system. Control of different inflammatory cytokines, such as nitric oxide (NO), interleukins (IL), tumor necrosis factor alpha-(TNF-α), noncytokine ...
Thanasekaran Jayakumar +4 more
doaj +3 more sources
Ruthenium Anticancer Compounds: Challenges and Expectations
CHIMIA, 2007 Two ruthenium compounds, namely [ImH]trans-[RuCl4(Im)(dmso-S)] (NAMI-A, Im = imidazole) and [IndH] trans-[RuCl4(Ind)2] (KP1019, Ind = indazole) have already completed phase I clinical trials as anticancer agents.
Ioannis Bratsos +3 more
doaj +5 more sources
Rational Design of Organo-Ruthenium Anticancer Compounds
CHIMIA, 2005 Organometallic ruthenium(II)-arene complexes are currently attracting increasing interest as anticancer compounds with the potential to overcome drawbacks of traditional drugs like cisplatin with respect to resistance, selectivity, and toxicity.
Christian Gossens +2 more
doaj +3 more sources
Pt-Ru Alloy Catalysts with Doped CeO2 Interlayer for Methane Conversion [PDF]
한국정밀공학회지, 2020 The necessity of converting toxic gas has arisen from the usage of perfluorinated compounds (PFCs), volatile organic compounds (VOCs), and hydrocarbon gases in the semiconductor process and laboratories.
Min Jong Kil +9 more
doaj +1 more source
The Behavior of Ruthenium in Copper Electrowinning
Metals, 2022 The recycling of material containing precious metals can lead to the entry of ruthenium into the copper electrowinning process, by so far unknown effects. There, ruthenium is oxidized to highly volatile ruthenium tetroxide.
Alexandra Thiere +2 more
doaj +1 more source
New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
Pharmaceutics, 2023 The combination of one molecule of organic and metal-based fragments that exhibit antitumor activity is a modern approach in the search for new promising drugs.
Ilya A. Shutkov +8 more
doaj +1 more source
Pharmaceutics, 2021 Despite some limitations such as long-term side effects or the potential presence of intrinsic or acquired resistance, platinum compounds are key therapeutic components for the treatment of several solid tumors. To overcome these limitations, maintaining
Elena Domínguez-Jurado +8 more
doaj +1 more source
Mechanochemical synthesis of intermetallic compounds in the system gallium – ruthenium
Chimica Techno Acta, 2021 The interaction of a solid inert metal Ru with liquid active metal Ga during mechanical activation in a high-energy planetary ball mill was studied using the X-ray diffraction and the high resolution scanning electron microscopy with energy dispersive X ...
T. F. Grigoreva +3 more
doaj +1 more source
Molbank, 2022 Bexarotene-tethered RuII(arene) compounds with 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (PTA) were prepared as an analog of RAPTA antitumor complexes in order to evaluate their in vitro antiproliferative activity against human cancer cell lines.
Ilya A. Shutkov +4 more
doaj +1 more source
A Combination of Ruthenium Complexes and Photosensitizers to Treat Colorectal Cancer
Inorganics, 2023 Treatment regimens are regularly evolving alongside novel therapies and drugs. Such evolution is necessary to circumvent resistance mechanisms and to give patients the best possible health care.
Jacquie Massoud +9 more
doaj +1 more source